BPL Ltd: Intrinsic Value & Share Price Analysis

Last Updated: January 22, 2026, 1:04 pm

All Competitor Stocks of BPL Ltd

Last Updated: January 2, 2026, 5:01 am

Below is a detailed analysis of the quarterly data for BPL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Sales, as of Sep 2025, the value is 19.84 Cr.. The value appears strong and on an upward trend. It has increased from 19.48 Cr. (Jun 2025) to 19.84 Cr., marking an increase of 0.36 Cr..
• For Expenses, as of Sep 2025, the value is 19.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.13 Cr. (Jun 2025) to 19.29 Cr., marking an increase of 3.16 Cr..
• For Operating Profit, as of Sep 2025, the value is 0.55 Cr.. The value appears to be declining and may need further review. It has decreased from 3.35 Cr. (Jun 2025) to 0.55 Cr., marking a decrease of 2.80 Cr..
• For OPM %, as of Sep 2025, the value is 2.77%. The value appears to be declining and may need further review. It has decreased from 17.20% (Jun 2025) to 2.77%, marking a decrease of 14.43%.
• For Other Income, as of Sep 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 0.37 Cr. (Jun 2025) to 0.16 Cr., marking a decrease of 0.21 Cr..
• For Interest, as of Sep 2025, the value is 0.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.38 Cr. (Jun 2025) to 0.30 Cr., marking a decrease of 0.08 Cr..
• For Depreciation, as of Sep 2025, the value is 0.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.60 Cr. (Jun 2025) to 0.61 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Sep 2025, the value is -0.20 Cr.. The value appears to be declining and may need further review. It has decreased from 2.74 Cr. (Jun 2025) to -0.20 Cr., marking a decrease of 2.94 Cr..
• For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
• For Net Profit, as of Sep 2025, the value is -0.20 Cr.. The value appears to be declining and may need further review. It has decreased from 2.74 Cr. (Jun 2025) to -0.20 Cr., marking a decrease of 2.94 Cr..
• For EPS in Rs, as of Sep 2025, the value is -0.04. The value appears to be declining and may need further review. It has decreased from 0.56 (Jun 2025) to -0.04, marking a decrease of 0.60.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 5:32 am

Last Updated: September 5, 2025, 1:20 am

Last Updated: December 4, 2025, 1:04 am

Below is a detailed analysis of the balance sheet data for BPL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 49.00 Cr..
• For Reserves, as of Sep 2025, the value is 203.00 Cr.. The value appears strong and on an upward trend. It has increased from 201.00 Cr. (Mar 2025) to 203.00 Cr., marking an increase of 2.00 Cr..
• For Borrowings, as of Sep 2025, the value is 106.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 8.00 Cr. (Mar 2025) to 106.00 Cr., marking an increase of 98.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 187.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 185.00 Cr. (Mar 2025) to 187.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 546.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 443.00 Cr. (Mar 2025) to 546.00 Cr., marking an increase of 103.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 240.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 240.00 Cr..
• For Other Assets, as of Sep 2025, the value is 280.00 Cr.. The value appears strong and on an upward trend. It has increased from 176.00 Cr. (Mar 2025) to 280.00 Cr., marking an increase of 104.00 Cr..
• For Total Assets, as of Sep 2025, the value is 546.00 Cr.. The value appears strong and on an upward trend. It has increased from 443.00 Cr. (Mar 2025) to 546.00 Cr., marking an increase of 103.00 Cr..

Notably, the Reserves (203.00 Cr.) exceed the Borrowings (106.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for BPL Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 2.76 (Mar 24) to -0.04, marking a decrease of 2.80.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 2.76 (Mar 24) to -0.04, marking a decrease of 2.80.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 3. It has decreased from 3.14 (Mar 24) to 0.48, marking a decrease of 2.66.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 50.91. It has decreased from 50.94 (Mar 24) to 50.91, marking a decrease of 0.03.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 50.91. It has decreased from 50.94 (Mar 24) to 50.91, marking a decrease of 0.03.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 16.00. It has increased from 13.56 (Mar 24) to 16.00, marking an increase of 2.44.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.45. This value is within the healthy range. It has increased from 4.01 (Mar 24) to 14.45, marking an increase of 10.44.
• For PBIT / Share (Rs.), as of Mar 25, the value is 13.98. This value is within the healthy range. It has increased from 3.61 (Mar 24) to 13.98, marking an increase of 10.37.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 3.44 (Mar 24) to 0.03, marking a decrease of 3.41.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 2. It has decreased from 2.74 (Mar 24) to 0.01, marking a decrease of 2.73.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has decreased from 2.74 (Mar 24) to 0.05, marking a decrease of 2.69.
• For PBDIT Margin (%), as of Mar 25, the value is 90.30. This value is within the healthy range. It has increased from 29.59 (Mar 24) to 90.30, marking an increase of 60.71.
• For PBIT Margin (%), as of Mar 25, the value is 87.38. This value exceeds the healthy maximum of 20. It has increased from 26.60 (Mar 24) to 87.38, marking an increase of 60.78.
• For PBT Margin (%), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 10. It has decreased from 25.39 (Mar 24) to 0.21, marking a decrease of 25.18.
• For Net Profit Margin (%), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. It has decreased from 20.18 (Mar 24) to 0.12, marking a decrease of 20.06.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 8. It has decreased from 20.18 (Mar 24) to 0.31, marking a decrease of 19.87.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 15. It has decreased from 5.37 (Mar 24) to 0.09, marking a decrease of 5.28.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.87. This value is within the healthy range. It has increased from 4.35 (Mar 24) to 16.87, marking an increase of 12.52.
• For Return On Assets (%), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 2.17 (Mar 24) to 0.04, marking a decrease of 2.13.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.08.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.12 (Mar 24) to 0.11, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.12. It has increased from 0.10 (Mar 24) to 0.12, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1.5. It has decreased from 0.27 (Mar 24) to 0.26, marking a decrease of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 1. It has decreased from 0.25 (Mar 24) to 0.24, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 15.54. This value exceeds the healthy maximum of 8. It has increased from 14.44 (Mar 24) to 15.54, marking an increase of 1.10.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.99 (Mar 24) to 0.00, marking a decrease of 99.99.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.99 (Mar 24) to 0.00, marking a decrease of 99.99.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 32.82. This value is within the healthy range. It has increased from 24.48 (Mar 24) to 32.82, marking an increase of 8.34.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 31.73. This value is within the healthy range. It has increased from 17.70 (Mar 24) to 31.73, marking an increase of 14.03.
• For Enterprise Value (Cr.), as of Mar 25, the value is 511.43. It has decreased from 585.09 (Mar 24) to 511.43, marking a decrease of 73.66.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.53. This value exceeds the healthy maximum of 3. It has decreased from 8.81 (Mar 24) to 6.53, marking a decrease of 2.28.
• For EV / EBITDA (X), as of Mar 25, the value is 7.23. This value is within the healthy range. It has decreased from 29.76 (Mar 24) to 7.23, marking a decrease of 22.53.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.45. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 4.45, marking a decrease of 2.02.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.98 (Mar 24) to 0.00, marking a decrease of 99.98.
• For Price / BV (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.72 (Mar 24) to 1.40, marking a decrease of 0.32.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.45. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 4.45, marking a decrease of 2.02.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.00, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis